DEUTSCHE BANK AG\ - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 213 filers reported holding DENALI THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.4%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,403,355
-43.8%
116,498
-19.6%
0.00%0.0%
Q2 2023$4,275,320
+41.9%
144,877
+10.8%
0.00%0.0%
Q1 2023$3,011,996
-2.2%
130,729
+18.1%
0.00%0.0%
Q4 2022$3,079,402
-0.5%
110,730
+9.8%
0.00%0.0%
Q3 2022$3,095,000
-4.7%
100,850
-8.6%
0.00%0.0%
Q2 2022$3,247,000
-10.6%
110,297
-2.3%
0.00%0.0%
Q1 2022$3,632,000
-31.2%
112,914
-4.6%
0.00%0.0%
Q4 2021$5,277,000
-9.8%
118,332
+2.0%
0.00%
-33.3%
Q3 2021$5,853,000
-36.2%
116,016
-0.9%
0.00%
-25.0%
Q2 2021$9,180,000
+173.5%
117,038
+99.1%
0.00%
+100.0%
Q1 2021$3,357,000
-22.8%
58,789
+13.3%
0.00%
-33.3%
Q4 2020$4,346,000
+197.3%
51,887
+27.2%
0.00%
+200.0%
Q3 2020$1,462,000
+45.3%
40,777
-2.0%
0.00%0.0%
Q2 2020$1,006,000
-18.9%
41,622
-41.2%
0.00%0.0%
Q1 2020$1,240,000
-15.4%
70,799
-15.9%
0.00%0.0%
Q4 2019$1,465,000
-8.0%
84,206
-19.0%
0.00%0.0%
Q3 2019$1,592,000
+57.3%
103,990
+112.8%
0.00%0.0%
Q2 2019$1,012,000
+66.4%
48,868
+85.7%
0.00%
Q1 2019$608,000
+8.4%
26,319
-3.1%
0.00%
Q4 2018$561,000
-86.8%
27,168
-86.1%
0.00%
-100.0%
Q3 2018$4,234,000
+354.8%
194,829
+218.5%
0.00%
Q2 2018$931,000
+123.3%
61,174
+188.1%
0.00%
Q1 2018$417,00021,2320.00%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Crestline Management, LP 19,462,500$298,165,00048.02%
Bratton Capital Management, L.P. 953,035$14,600,00028.53%
Flagship Pioneering Inc. 8,005,747$122,648,0006.71%
Casdin Capital, LLC 650,000$9,958,000,0001.03%
Temasek Holdings (Private) Ltd 4,410,457$67,568,0000.50%
MARK ASSET MANAGEMENT LP 68,864$1,055,0000.26%
IRONWOOD INVESTMENT MANAGEMENT LLC 22,507$345,0000.26%
Artal Group S.A. 400,000$6,128,0000.25%
PIER 88 INVESTMENT PARTNERS LLC 40,610$622,0000.24%
HAMILTON LANE ADVISORS LLC 30,948$474,0000.20%
View complete list of DENALI THERAPEUTICS INC shareholders